DaAn Gene Overview
- Year Founded
-
1988
- Status
-
Public
- Employees
-
1,334
- Stock Symbol
-
002030
- Investments
-
11
- Share Price
-
$0.78
- (As of Friday Closing)
DaAn Gene General Information
Description
Daan Gene Co Ltd is a company that focuses on molecular diagnostic technology and integrates the research, development, production, and sales of clinical testing reagents and instruments.
Contact Information
Website
www.daangene.comCorporate Office
- Number 19 Xiangshan Road, Guangzhou High-tech Industrial Development Zone
- Guangzhou, Guangdong 510665
- China
Corporate Office
- Number 19 Xiangshan Road, Guangzhou High-tech Industrial Development Zone
- Guangzhou, Guangdong 510665
- China
DaAn Gene Stock Performance
As of 13-Nov-2026, DaAn Gene’s stock price is $0.78. Its current market cap is $1.09B with 1.4B shares.
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $0.78 | $0.80 | $0.71 - $1.18 | $1.09B | 1.4B | 23.5M | -$0.08 |
DaAn Gene Financials Summary
As of 30-Sep-2026, DaAn Gene has a trailing 12-month revenue of $113M.
|
In Thousands, USD |
TTM 30-Sep-2026 | FY 2025 31-Dec-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 |
|---|---|---|---|---|
| EV | 1,083,553 | 1,120,948 | 1,025,573 | 1,844,209 |
| Revenue | 112,646 | 105,358 | 118,881 | 166,914 |
| EBITDA | (111,879) | (69,718) | (108,764) | 56,201 |
| Net Income | (107,791) | (103,511) | (128,935) | 14,793 |
| Total Assets | 1,230,622 | 1,216,360 | 1,311,888 | 1,554,315 |
| Total Debt | 14,306 | 16,398 | 22,971 | 51,932 |
DaAn Gene Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
DaAn Gene Patents
DaAn Gene Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2021093845-A1 | Thermostable reverse transcriptase mutant and use thereof | Inactive | 13-Nov-2019 | ||
| WO-2016197843-A1 | Fluorescence detection primer, detection method, and detection kit for culex wolbachia | Inactive | 11-Jun-2015 | ||
| WO-2016197842-A1 | Fluorescence detection primer, detection method, and detection kit for type-a and type-b wolbachia | Inactive | 11-Jun-2015 | ||
| WO-2016197837-A1 | Fluorescence detection primers of three types of wolbachia and detection method and detection kit thereof | Inactive | 11-Jun-2015 | C12Q1/689 |
DaAn Gene Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
DaAn Gene Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
DaAn Gene Investments (11)
DaAn Gene’s most recent deal was a Later Stage VC with MSTech(Hangzhou). The deal was made on 07-Mar-2025.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| MSTech(Hangzhou) | 07-Mar-2025 | Later Stage VC | Electrical Equipment | ||
| Darui Biotechnology | 03-Aug-2021 | Later Stage VC | Diagnostic Equipment | ||
| Aricon | 22-Jan-2017 | Early Stage VC | Monitoring Equipment | ||
| Dearcare | 29-Dec-2016 | Early Stage VC | Therapeutic Devices | ||
| Yunfubao Daily Necessities | 28-Dec-2016 | Early Stage VC | Specialty Retail |
DaAn Gene ESG
Risk Overview
Risk Rating
Updated November, 04, 2026
32.96 | High Risk
Risk Scale
A lower score indicates better sustainability
Negl
0-10
Low
10-20
Med
20-30
High
30-40
Severe
40+
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
Management
Management is related to actions taken to manage ESG issues
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
of 13,585
Rank
Percentile
Pharmaceuticals
Industry
of 852
Rank
Percentile
Biotechnology
Subindustry
of 431
Rank
Percentile
DaAn Gene Exits (3)
DaAn Gene’s most recent exit was on 09-Jan-2015 from ClinMeta. The exit was categorized as with 2 buyers.
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| ClinMeta | 09-Jan-2015 | Completed |
|
||
| Basecare | 25-Apr-2014 | Completed |
|
||
| Guangzhou Ambition (LBP) Pharmaceutical Technology | 01-Dec-2011 | Later Stage VC | Completed |
DaAn Gene Affiliates
Subsidiaries (1)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Darui Biotechnology | Guangzhou, China | 2003 |
DaAn Gene FAQs
-
When was DaAn Gene founded?
DaAn Gene was founded in 1988.
-
Where is DaAn Gene headquartered?
DaAn Gene is headquartered in Guangzhou, China.
-
What is the size of DaAn Gene?
DaAn Gene has 1,334 total employees.
-
What industry is DaAn Gene in?
DaAn Gene’s primary industry is Diagnostic Equipment.
-
Is DaAn Gene a private or public company?
DaAn Gene is a Public company.
-
What is DaAn Gene’s stock symbol?
The ticker symbol for DaAn Gene is 002030.
-
What is the current stock price of DaAn Gene?
As of 13-Nov-2026 the stock price of DaAn Gene is $0.78.
-
What is the current market cap of DaAn Gene?
The current market capitalization of DaAn Gene is $1.09B.
-
What is DaAn Gene’s current revenue?
The trailing twelve month revenue for DaAn Gene is $113M.
-
What is DaAn Gene’s annual earnings per share (EPS)?
DaAn Gene’s EPS for 12 months was -$0.08.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
